USTEKINUMAB REFERENCES (click here for other references)
Feagan BG, Sandborn WJ, Gasink C, et al. Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease. N Engl J Med. 2016;375(20):1946-1960. doi:10.1056/NEJMoa1602773.
Strober W, Zhang F, Kitani A, Fuss I, Fichtner-Feigl S. Proinflammatory cytokines underlying the inflammation of Crohn’s disease. Curr Opin Gastroenterol. 2010;26(4):310-317. doi:10.1097/MOG.0b013e328339d099.
Wang K, Zhang H, Kugathasan S, et al. Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease. Am J Hum Genet. 2009;84(3):399-405. doi:10.1016/j.ajhg.2009.01.026.
PrSTELARA® ustekinumab injection sterile solution 45 mg/0.5 mL 90 mg/1.0 mL [product monograph]. Toronto: Janssen Inc; Dec 12, 2008.
